Skip to main navigation
Main navigation
About
Who We Are
Management
Board of Directors
Scientific Advisory Board
Pipeline
Generics
Technology
Therapeutic Areas
Acne Vulgaris
Subtype II Papulopustular Rosacea
Palmoplantar Keratoderma
Investors
Investor Overview
Press Releases
Events & Presentations
Corporate Governance
Analyst Coverage
Financial Information
Proxy Statements
Stock Information
Shareholder Services
Contact
Proxy Statements
Sol-Gel Proxy Statement for AGM May 2018
220.1 KB
Sol-Gel Proxy Statement March 2018
131.1 KB
Shareholder Tools
Print
Print
Email Alerts
Email Alerts
RSS Feeds
RSS Feeds